Docefrez

E902897

Docefrez is a branded formulation of the chemotherapy drug docetaxel used to treat various cancers, including breast, lung, and prostate cancer.

All labels observed (1)

Label Occurrences
Docefrez canonical 1

How this entity was disambiguated

Statements (39)

Predicate Object
instanceOf chemotherapy drug ⓘ
pharmaceutical brand ⓘ
administeredBy healthcare professional ⓘ
affects microtubule depolymerization ⓘ
belongsToClass taxane chemotherapy ⓘ
causes apoptosis in cancer cells ⓘ
commonAdverseEffect alopecia ⓘ
anemia ⓘ
fatigue ⓘ
nausea ⓘ
neutropenia ⓘ
peripheral neuropathy ⓘ
contains docetaxel anhydrous ⓘ
contraindicatedIn severe hepatic impairment ⓘ
drugClass antineoplastic agent ⓘ
formulationType injectable concentrate ⓘ
hasActiveIngredient docetaxel ⓘ
indicatedFor hormone-refractory metastatic prostate cancer ⓘ
locally advanced breast cancer ⓘ
metastatic breast cancer ⓘ
metastatic non-small cell lung cancer ⓘ
induces cell cycle arrest at G2/M phase ⓘ
mayCause hypersensitivity reactions ⓘ
mechanismOfAction microtubule stabilizer ⓘ
mitotic inhibitor ⓘ
oftenGivenWith corticosteroid premedication ⓘ
originatesFrom semi-synthetic derivative of paclitaxel-related compounds ⓘ
pregnancyCategory teratogenic risk ⓘ
regulatoryStatus prescription-only medicine ⓘ
requires dilution before infusion ⓘ
prescription ⓘ
requiresMonitoring blood cell counts ⓘ
routeOfAdministration intravenous infusion ⓘ
storageCondition controlled room temperature ⓘ
targets rapidly dividing cells ⓘ
usedFor breast cancer ⓘ
cancer treatment ⓘ
non-small cell lung cancer ⓘ
prostate cancer ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Docetaxel → tradeName → Docefrez ⓘ
subject linked to: docetaxel